Valenton, France

Narimane Zeghbib

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Narimane Zeghbib: Innovator in Neurodegenerative Disease Research

Introduction

Narimane Zeghbib is a prominent inventor based in Valenton, France. She has made significant contributions to the field of neurodegenerative diseases, particularly through her innovative research and patenting efforts. Her work focuses on developing chemical models that can aid in understanding and treating conditions like Parkinson's disease.

Latest Patents

Narimane Zeghbib holds a patent titled "Chemical model of a neurodegenerative disease, method for preparation and uses of same." This invention involves the use of pyridinium furosemide or its derivatives in creating a chemical model of a neurodegenerative disease, specifically Parkinson's disease. The patent outlines the preparation methods and potential applications of this model, particularly in screening tests for identifying drug candidates.

Career Highlights

Throughout her career, Narimane has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université Paris Est Créteil Val de Marne. Her research has been pivotal in advancing the understanding of neurodegenerative diseases and developing new therapeutic approaches.

Collaborations

Narimane has collaborated with notable colleagues, including Thierry Martens and Michaël Rivard. These partnerships have enriched her research and contributed to the success of her innovative projects.

Conclusion

Narimane Zeghbib's work exemplifies the vital role of innovation in addressing complex health challenges. Her contributions to neurodegenerative disease research through her patent and collaborations highlight her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…